Alternate-Day Buprenorphine Administration. Phase VI
Alternate-Day Buprenorphine Administration. Phase VI
The purpose of this study is to determine if four times a subject's daily maintenance dose will hold for 96 hours without changes in agonist and antagonist effects.
Please contact site for information.